Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2005
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271721 Carvedilol-hydrophilic solutions
12/08/2005US20050271718 Sustained release propafenone hydrochloride capsules
12/08/2005US20050271673 Trifunctional reagent for conjugation to a biomolecule
12/08/2005US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof
12/08/2005US20050271631 Material compositions and related systems and methods for treating cardiac conditions
12/08/2005DE60017281T2 Nomegestrolacetat und östrogen enthaltende Hormonzusammensetzung und ihre Verwendung Nomegestrol acetate and estrogen hormone-containing composition and its use
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568547A1 Composition comprising fermented tea extract as the main component and having effect of elevating adiponectin level
12/08/2005CA2567969A1 Compositions comprising flavonoids and tocotrienols and methods thereof
12/08/2005CA2567963A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005CA2566202A1 Agent for preventing/ameliorating life style-related diseases containing turmeric essential oil component
12/07/2005EP1602660A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602657A2 Substituted 9-alkyladenines
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602652A1 Adiponectin expression promoter
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602372A1 Drug for improving prognosis for subarachnoid hemorrhage
12/07/2005EP1602370A2 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
12/07/2005EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
12/07/2005EP1601675A1 Purin-6-one-derivatives
12/07/2005EP1601666A2 New neuropeptide y y5 receptor antagonists
12/07/2005EP1601392A1 Compositions for use in embolizing blood vessels comprising high levels of contrast agent
12/07/2005EP1601362A2 Use of diazoxide in the treatment of ischemia retinae
12/07/2005EP1601351A1 Use of ep2 selective receptor agonists in medical treatment
12/07/2005EP1601349A1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament
12/07/2005EP1601251A2 Compounds for the treatment of metabolic disorders
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1499607B1 4-(piperidyl- and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1317439B1 Acid-sensitive compounds, preparation and uses thereof
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1217001B1 Quinuclidine compounds and drugs containing the same as the active ingredient
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1196129B1 Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1124548B1 Compositions for the treatment and prevention of cardiovascular diseases
12/07/2005EP1117426B1 Akt compositions for enhancing survival of cardiomyocytes
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705648A Alpha-phenyl acetanilide derivatives having an ACAT inhibiting activity and the therapeutic application thereof
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1704121A Anti-angiogenic compositions and methods of use
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230441C Integrin binding peptide derivatives
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230201C Blood-platelet specific mosaic immune globulin and its using method
12/07/2005CN1230195C Oral preparation containing seaweed for reduction of plaque and calculus
12/07/2005CN1230182C Method for preventing and reversing atherosclerosis in mammals
12/07/2005CN1230179C Micronized eplerenone compositions
12/07/2005CN1230175C Ligustrazine hydrochloride freeze-dried preparation for injection and its preparing method
12/07/2005CN1230173C Preventives and remedies for complications of diabetes
12/07/2005CN1230172C Blood circulation improving agent
12/07/2005CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/07/2005CN1230161C Persimmon leaf extract and its preparation and its usage
12/07/2005CN1230159C Essential fatty acids in prevention of cardiovascular events
12/07/2005CN1230158C Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof
12/07/2005CN1230131C Therapeutic use of polymers
12/07/2005CA2469339A1 Sustained release propafenone hydrochloride capsules
12/07/2005CA2469327A1 Propafenone hydrochloride capsules containing microtablets
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972298 Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972282 Process for producing a product containing antihypertensive tripeptides
12/06/2005US6972176 KVLQT1—a long QT syndrome gene
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2331873C Fumagillol derivatives and processes for preparing the same
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/06/2005CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
12/02/2005CA2509077A1 Water-based compositions comprising a polyethylene glycol-based solubilizing agent and a taxane useful in the treatment of coronary artery disease
12/01/2005WO2005113541A1 Pyrrole compounds as inhibitors of erk protein kinase, synthesis thereof and intermediates thereto
12/01/2005WO2005113540A1 Isoquinoline compound and pharmaceutical use thereof
12/01/2005WO2005112944A1 Drug for prevention or treatment of diabetes
12/01/2005WO2005112904A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267215 Abca-1 elevating compounds
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267198 Novel processes for preparing amorphous atorvastatin hemi-calcium
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
1 ... 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 ... 1595